| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/22/2005 | EP1542723A2 Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
| 06/22/2005 | EP1542721A1 Modified "s" antibodies |
| 06/22/2005 | EP1542720A2 Treatment of tnf alpha related disorders |
| 06/22/2005 | EP1542719A2 Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/22/2005 | EP1542718A2 Peptide derivative fusion inhibitors of hiv infection |
| 06/22/2005 | EP1542717A1 Improvements in or relating to vaccines |
| 06/22/2005 | EP1542609A2 Methods for up-regulating antigen expression in tumors |
| 06/22/2005 | EP1542528A1 A method of treatment and prophylaxis |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1124849B1 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 06/22/2005 | EP1073465B1 T cell inhibitory receptor compositions and uses thereof |
| 06/22/2005 | EP0758397B1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 06/22/2005 | CN1630819A Renal cell carcinoma markers |
| 06/22/2005 | CN1630708A Osteoclast-associated receptor |
| 06/22/2005 | CN1630665A Anti-A beta antibodies and their use |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 06/22/2005 | CN1630662A Rabbit hemorrhagic disease vaccine and antigens |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630531A Composition comprising immunogenic microparticles |
| 06/22/2005 | CN1630530A Polyalkylene polymer compounds and uses thereof |
| 06/22/2005 | CN1630529A B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630514A Methods and compositions for control of bone formation via modulation of sympathetic tone |
| 06/22/2005 | CN1630494A Ophthalmic drug delivery device |
| 06/22/2005 | CN1629185A Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/22/2005 | CN1628858A Method for inducing immune response using HBs DNA vaccine inoculated by HBV core protein reinforcing gene gun |
| 06/22/2005 | CN1628847A Method of treating vertebrates virosis by virus vaccine |
| 06/22/2005 | CN1628846A Viral vaccine for the treatment of viral disease |
| 06/22/2005 | CN1207389C Genetically engineered body of somatostatin gene vaccine (DNA vaccine) |
| 06/22/2005 | CN1207306C Peptide compound for preventing and treating HIV infection and immunity diseases |
| 06/22/2005 | CN1207005C Rabbit skin containing bioactive substance and its use |
| 06/21/2005 | US6908994 Collagen-binding proteins from enterococcal bacteria |
| 06/21/2005 | US6908620 Coccidial vaccine and methods of making and using same |
| 06/21/2005 | US6908619 Isolated nucleic acid molecule consisting of sequence encoding immunogenic polypeptide having at least 90% sequence identity to specified contiguous amino acid sequence |
| 06/21/2005 | US6908618 Production of novel bovine respiratory syncytial viruses from cDNAs |
| 06/21/2005 | US6908616 Composition suitable for immunizing crustaceans by injection against White Spot Syndrome Virus, WSSV, comprising isolated protein consisting of specified amino acid sequence, which delays mortality against WSSV infectivity in crustaceans |
| 06/21/2005 | US6908615 DNA encoding human papilloma virus type 18 |
| 06/21/2005 | US6908613 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/21/2005 | US6908612 Virus coat protein/receptor chimeras and methods of use |
| 06/21/2005 | US6908605 Non-invasive localization of a light-emitting conjugate in a mammal |
| 06/21/2005 | CA2304926C Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 06/21/2005 | CA2182303C Method of preparing a viral vector by homologous intermolecular recombination |
| 06/21/2005 | CA2164155C A polysaccharide vaccine to enhance immunity against brucellosis |
| 06/21/2005 | CA2145005C Monoclonal antibodies specific for tcf-ii |
| 06/21/2005 | CA2015677C Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines |
| 06/19/2005 | CA2494572A1 Cytochrome p450 24 (cyp24) monoclonal antibody and methods and uses thereof |
| 06/16/2005 | WO2005054484A1 Promoters for expression in modified vaccinia virus ankara |
| 06/16/2005 | WO2005054473A1 GENETICALLY MODIFIED PLANTS COMPRISING SARS-CoV VIRAL NUCLEOTIDE SEQUENCES AND METHODS OF USE THEREOF FOR IMMUNIZATION AGAINST SARS |
| 06/16/2005 | WO2005054451A1 Highly safe smallpox vaccine virus and vaccinia virus vector |
| 06/16/2005 | WO2005054434A2 Use of notch pathway interfering agents for treatment of plasma cell disorders |
| 06/16/2005 | WO2005054292A1 Compositions and methods related to a dimeric mhc class i and ii-like molecule (dsmhc i and dsmhc ii) |
| 06/16/2005 | WO2005054282A1 Protein nmb0928 and use thereof in pharmaceutical formulations |
| 06/16/2005 | WO2005054281A2 Protein nmb1125 and use thereof in pharmaceutical formulations |
| 06/16/2005 | WO2005054258A2 New class of gamma delta t cells activators and use thereof |
| 06/16/2005 | WO2005053795A2 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
| 06/16/2005 | WO2005053743A1 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer |
| 06/16/2005 | WO2005053742A1 Medicine containing antibody composition |
| 06/16/2005 | WO2005053741A1 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 06/16/2005 | WO2005053740A1 Immune enhancer and enhanced antigen obtained therewith |
| 06/16/2005 | WO2005053739A2 Combination therapy |
| 06/16/2005 | WO2005053738A1 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 06/16/2005 | WO2005053737A1 In ovo vaccination of campylobacter in avian species |
| 06/16/2005 | WO2005053736A1 Oral vaccine, method for its preparation and use thereof |
| 06/16/2005 | WO2005053717A1 Stabilisation of viral microparticles |
| 06/16/2005 | WO2005053716A1 Streptococcus phocae vaccine |
| 06/16/2005 | WO2005053649A1 Biofunctionalized quantum dots for biological imaging |
| 06/16/2005 | WO2005053505A2 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 06/16/2005 | WO2005044293A3 Compositions able to prevent neurodegenerative processes and methods of assaying the same |
| 06/16/2005 | WO2005041877A3 Method of inhibiting rejection following organ transplantation |
| 06/16/2005 | WO2005026370A3 Multi-antigen vectors for melanoma |
| 06/16/2005 | WO2005024032A3 Targeting adenoviral vectors to dendritic cells |
| 06/16/2005 | WO2005023862A3 Homogeneous preparations of il-28 and il-29 |
| 06/16/2005 | WO2005014862B1 Methods of producing inflenza vaccine compositions |
| 06/16/2005 | WO2005014645A3 Pedf-r receptor and uses |
| 06/16/2005 | WO2005013920A3 Newcastle disease virus administration |
| 06/16/2005 | WO2005013899A9 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/16/2005 | WO2005010167A3 Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections |
| 06/16/2005 | WO2005004800A3 Trypanosome derived apoptotic factors (taf) |
| 06/16/2005 | WO2004106367A3 Enterococcus antigens |
| 06/16/2005 | WO2004084936A3 Modified free-living microbes, vaccine compositions and methods of use thereof |
| 06/16/2005 | WO2004084816A3 IMPROVED CD4-IgG2 FORMULATIONS |
| 06/16/2005 | WO2004081199A3 Novel compositions and methods for the treatment of immune related disease |
| 06/16/2005 | WO2004071404A3 Use of il-6 antagonists in combination with steroids to enhance apoptosis |
| 06/16/2005 | WO2004069159A3 Vitamin receptor binding drug delivery conjugates |
| 06/16/2005 | WO2004060280A3 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 06/16/2005 | WO2004053072A3 Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| 06/16/2005 | WO2004040976A8 Cryogenically protected viral delivery systems and related manufacture and use |
| 06/16/2005 | WO2004035006A3 Methods and compositions for immunization against hiv |
| 06/16/2005 | WO2004031360A3 Therapeutic aptamers having binding specificity to gp41 of hiv |
| 06/16/2005 | WO2003012072A3 Monoclonal antibodies to activated erbb family members and methods of use thereof |
| 06/16/2005 | WO1990004979A8 Method of preventing or reducing eosinophilia |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131221 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 06/16/2005 | US20050131216 Reagents for detecting efavirenz |
| 06/16/2005 | US20050131210 Genes and proteins, and their use |
| 06/16/2005 | US20050131051 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon |
| 06/16/2005 | US20050130965 Inhibitors of p38 kinase |
| 06/16/2005 | US20050130942 (E)-2,4,6-trimethoxystyryl-4-methoxy-3-aminobenzylsulfone for example; cancer, tumors, multiple sclerosis, Pagets disease; antibody conjugates; target receptor tyrosine kinases and which arrest the Ras/Raf/MEK/ERK kinase cascade |